Skip to main content
NVDA-2.30%AAPL+3.37%GOOGL+0.60%MSFT+0.16%AMZN-0.27%TSM-1.46%SPCX+0.04%AVGO-1.03%META-1.45%TSLA-1.26%SKHY-5.17%MU-4.80%BRK-B+0.11%LLY-0.01%JPM-0.41%WMT-0.07%AMD-3.27%V+0.04%XOM+0.72%ASMLa-1.66%JNJ-0.31%INTC-5.37%MA-0.31%0700.HK-1.94%1398.HK+0.79%ORCL-4.76%ABBV+1.45%BAC-0.17%CSCO-1.64%CVX-0.43%COST+0.03%KO+0.51%LRCX-5.73%CAT-1.43%AP2d-1.55%0005.HK-0.78%AMAT-3.17%UNH-1.08%HSBA.L-1.30%DELL-4.76%PG+0.25%MS-1.03%GE-0.45%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.15%HD-1.70%0939.HK+1.66%GS-1.06%NZDJPY-2.62%AUDJPY-1.86%CHFJPY-1.61%NZDCAD-1.45%EURNZD+1.42%NZDUSD-1.41%GBPNZD+1.36%GBPJPY-1.27%EURJPY-1.25%USDJPY-1.24%CADJPY-1.19%NZDCHF-1.05%USDZAR+1.02%USDSEK+0.93%USDNOK+0.90%EURZAR+0.84%AUDNZD+0.79%GBPZAR+0.75%EURSEK+0.74%EURNOK+0.72%AUDCAD-0.70%USDTHB+0.70%AUDDKK-0.65%AUDUSD-0.63%EURAUD+0.62%CHFSEK+0.59%USDMXN+0.58%GBPAUD+0.57%CHFNOK+0.57%AUDSGD-0.55%USDPLN+0.44%GBPTRY+0.41%CADCHF+0.41%NZDSGD-0.40%NOKJPY-0.40%USDCHF+0.39%EURCHF+0.36%GBPCHF+0.33%GBPHKD+0.32%GBPMXN-0.28%USDSGD+0.28%EURPLN+0.26%AUDCHF-0.25%SGDJPY+0.22%EURHKD-0.19%USDDKK+0.18%USDILS+0.16%NZDMXN-0.12%USDTRY+0.11%USDCNH+0.10%EURSGD+0.10%GBPCAD-0.10%AUDNOK+0.07%EURCNH-0.06%EURCAD-0.06%PLNJPY+0.06%EURCZK-0.06%CHFSGD-0.05%EURGBP+0.04%USDCOP-0.04%USDCAD-0.04%GBPUSD-0.03%USDHKD+0.02%EURUSD-0.02%GBPSGD+0.01%EURDKK0.00%XPTUSD-6.24%UKOIL+5.70%USOIL+5.46%GAGUSD-5.34%XAGUSD-5.34%HG1-4.81%XAUUSD-1.76%GAUUSD-1.76%XNGUSD+1.51%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.51%ETHUSD-0.25%USDTUSD-0.02%XRPUSD-3.14%SOLUSD-1.78%TRXUSDT+0.18%ZECUSDT-9.66%DOGEUSD-2.61%XMRUSDT+0.15%LINKUSD-1.60%XLMUSD-1.85%BCHUSDT-9.95%LTCUSD-1.86%UNIUSD-1.29%TONUSD+24.88%HBARUSDT-2.36%SUIUSD-4.33%TAOUSDT-5.94%AAVEUSD-2.15%DOTUSDT-2.01%ICPUSDT-0.94%ONDOUSDT-3.59%WLDUSDT-3.39%ATOMUSDT-3.57%ARBUSDT-1.23%JUPUSDT-4.25%INJUSDT-3.17%STXUSDT-4.53%FETUSDT-3.21%TIAUSDT-1.65%PYTHUSDT-1.77%SEIUSDT-6.02%IMXUSDT-3.85%WIFUSDT-5.38%GRTUSDT-4.03%OPUSDT-4.00%POLUSDT-4.61%IOTAUSDT-4.39%AXSUSDT-2.47%FARTCOINUSDT-3.46%EOSUSDT-2.91%DYDXUSDT-2.53%ORDIUSDT-1.30%GALAUSDT-3.65%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.30%AAPL+3.37%GOOGL+0.60%MSFT+0.16%AMZN-0.27%TSM-1.46%SPCX+0.04%AVGO-1.03%META-1.45%TSLA-1.26%SKHY-5.17%MU-4.80%BRK-B+0.11%LLY-0.01%JPM-0.41%WMT-0.07%AMD-3.27%V+0.04%XOM+0.72%ASMLa-1.66%JNJ-0.31%INTC-5.37%MA-0.31%0700.HK-1.94%1398.HK+0.79%ORCL-4.76%ABBV+1.45%BAC-0.17%CSCO-1.64%CVX-0.43%COST+0.03%KO+0.51%LRCX-5.73%CAT-1.43%AP2d-1.55%0005.HK-0.78%AMAT-3.17%UNH-1.08%HSBA.L-1.30%DELL-4.76%PG+0.25%MS-1.03%GE-0.45%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.15%HD-1.70%0939.HK+1.66%GS-1.06%NZDJPY-2.62%AUDJPY-1.86%CHFJPY-1.61%NZDCAD-1.45%EURNZD+1.42%NZDUSD-1.41%GBPNZD+1.36%GBPJPY-1.27%EURJPY-1.25%USDJPY-1.24%CADJPY-1.19%NZDCHF-1.05%USDZAR+1.02%USDSEK+0.93%USDNOK+0.90%EURZAR+0.84%AUDNZD+0.79%GBPZAR+0.75%EURSEK+0.74%EURNOK+0.72%AUDCAD-0.70%USDTHB+0.70%AUDDKK-0.65%AUDUSD-0.63%EURAUD+0.62%CHFSEK+0.59%USDMXN+0.58%GBPAUD+0.57%CHFNOK+0.57%AUDSGD-0.55%USDPLN+0.44%GBPTRY+0.41%CADCHF+0.41%NZDSGD-0.40%NOKJPY-0.40%USDCHF+0.39%EURCHF+0.36%GBPCHF+0.33%GBPHKD+0.32%GBPMXN-0.28%USDSGD+0.28%EURPLN+0.26%AUDCHF-0.25%SGDJPY+0.22%EURHKD-0.19%USDDKK+0.18%USDILS+0.16%NZDMXN-0.12%USDTRY+0.11%USDCNH+0.10%EURSGD+0.10%GBPCAD-0.10%AUDNOK+0.07%EURCNH-0.06%EURCAD-0.06%PLNJPY+0.06%EURCZK-0.06%CHFSGD-0.05%EURGBP+0.04%USDCOP-0.04%USDCAD-0.04%GBPUSD-0.03%USDHKD+0.02%EURUSD-0.02%GBPSGD+0.01%EURDKK0.00%XPTUSD-6.24%UKOIL+5.70%USOIL+5.46%GAGUSD-5.34%XAGUSD-5.34%HG1-4.81%XAUUSD-1.76%GAUUSD-1.76%XNGUSD+1.51%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.51%ETHUSD-0.25%USDTUSD-0.02%XRPUSD-3.14%SOLUSD-1.78%TRXUSDT+0.18%ZECUSDT-9.66%DOGEUSD-2.61%XMRUSDT+0.15%LINKUSD-1.60%XLMUSD-1.85%BCHUSDT-9.95%LTCUSD-1.86%UNIUSD-1.29%TONUSD+24.88%HBARUSDT-2.36%SUIUSD-4.33%TAOUSDT-5.94%AAVEUSD-2.15%DOTUSDT-2.01%ICPUSDT-0.94%ONDOUSDT-3.59%WLDUSDT-3.39%ATOMUSDT-3.57%ARBUSDT-1.23%JUPUSDT-4.25%INJUSDT-3.17%STXUSDT-4.53%FETUSDT-3.21%TIAUSDT-1.65%PYTHUSDT-1.77%SEIUSDT-6.02%IMXUSDT-3.85%WIFUSDT-5.38%GRTUSDT-4.03%OPUSDT-4.00%POLUSDT-4.61%IOTAUSDT-4.39%AXSUSDT-2.47%FARTCOINUSDT-3.46%EOSUSDT-2.91%DYDXUSDT-2.53%ORDIUSDT-1.30%GALAUSDT-3.65%NOTUSDT-2.97%RONINUSDT-2.64%
BS

bioMérieux S.A. (BIMp)

Euronext Paris • Healthcare

€71.59
-€0.1 (-0.1%)
Market closed

September 10, 2026 at 15:30 UTC

Open€71.9
Day Range€71.55 - €72.95
Avg. Volume (3M)156.8K
Market Cap€8.4B
P/E Ratio18.2
52 Week Range
€65.6€117.3

Interactive Chart

20:03:59 UTC

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned€1.9B100%
Gross Profitminus cost of goods€1B55%
Operating Incomeminus R&D and overhead€299.2M15%
Net Incomeminus taxes and the rest€226.1M12%

In plain terms: out of every €100 in revenue, bioMérieux S.A. keeps €12 as net profit.

Fundamentals & Financials

Revenue (TTM)
€3.9B
Net Income (TTM)
€462.4M
EPS (TTM)
€3.93
ROA (TTM)
8.12%
Current Ratio
2.3
Dividend Yield
1.42%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

€1.18Q2 2019
-7.4%Q4 2019€1.12
-9.3%Q3 2020€1.46

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2020
Miss -9.3%

bioMérieux’s first half of fiscal 2026 results paired a revenue beat with an adjusted EPS miss, with figures reported July 28, 2026 showing revenue of EUR 1.965 billion topped the EUR 1.915 billion estimate, +2.6%, while adjusted EPS of EUR 1.97 trailed the EUR 2.01 estimate, -2.0%. Revenue fell 3.9% year over year to about EUR 2.0 billion (down from EUR 2.044 billion a year ago), and profitability was supported by a gross margin of ~55% and an operating margin of ~15%, with gross profit around EUR 1.1 billion and operating income near EUR 299 million. Net income rose 40.4% year over year to roughly EUR 226 million (up from EUR 161 million a year ago). The company generated operating cash flow of about EUR 437 million during the period and paid roughly EUR 115 million in dividends.

View full earnings history

About bioMérieux S.A.

bioMérieux S.A. develops and sells laboratory diagnostics and related testing services for the healthcare field, with EUR 4.1 billion in FY2025 revenue. Listed on Euronext Paris as BIM.PA, the company operates in medical diagnostics and research, supplying systems that analyze biological samples to detect disease and condition markers.

Name
bioMérieux S.A.
CEO
Pierre Boulud
Website
www.biomerieux.com
Industry
Healthcare
Year Founded
1963
Employees
14,894

Today's Snapshot

AI-generated

The day ended with BIMp slightly higher at 72.00, in line with a flat sector. Shares changed hands at about a sixth of its usual level.

Trading Volume

Below 10d avg (165.9K)

32.4K

vs S&P 500 Today

Outperforming Market

+0.89%

Updated: September 10, 2026 at 14:05 UTC

Technical Indicators

1 Buy1 Neutral6 Sell
BIMp is showing a cautious downside bias as the price sits just under short- and medium-term averages and well below the 200-day level, while VWAP and the pivot lie marginally above the market. Momentum readings are mixed but skew negative — CCI and MACD register bearish signals even as RSI remains neutral — and ADX indicates a weak trend, suggesting limited directional conviction. Volatility is moderate and ATR is steady, while OBV’s negative reading points to distribution. Technical takeaway: weak trend, negative momentum and below-major-moving-average placement support the sell stance.
All signals
  • EMA (5 indicators)$73.22 - $86.20
    Sell
  • RSI (14)40.65
    Neutral
  • Stochastic %K (14, 3, 3)5.67
    Buy
  • MACD Level (12, 26)-0.01
    Sell

Peers & Related Assets

ERFpEurofins Scientific SE
€70.92-0.0%
DIM.PASartorius Stedim Biotech S.A.
IPN.PAIpsen S.A.
ERF.PAEurofins Scientific SE
ABVX.PAAbivax S.A.
VIRP.PAVirbac S.A.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.